Vernakalant

Vernakalant is a medicine that is used to treat abnormal heart rhythms (arrhythmias). It works by blocking certain electrical signals in the heart that can cause arrhythmias. It is available as an injection or an oral tablet. Vernakalant is used to treat atrial fibrillation, a type of irregular heartbeat. It can also be used to prevent recurrences of atrial fibrillation after successful cardioversion (a procedure to restore a normal heart rhythm).

Vernakalant is a medication specifically designed to address a type of irregular heartbeat called atrial fibrillation (AF). It falls under the class III antiarrhythmic drugs. Here's a breakdown of Vernakalant's role in treating AF:

• Function: Vernakalant works by regulating the electrical activity within the heart, particularly in the upper chambers called atria. It targets potassium and sodium channels in heart cells, aiming to restore a normal heart rhythm by:
  • Prolonging the refractory period in the atria: This means it makes the heart muscle less susceptible to electrical impulses for a brief period, allowing for more coordinated contractions.
  • Being rate-dependent: Its effect becomes more pronounced at faster heart rates, which are common during AF episodes.
• Use: Vernakalant is administered intravenously (through a vein) in a hospital setting to convert recent-onset AF (lasting up to 3 days after heart surgery or 7 days otherwise) back to a normal heart rhythm, medically termed sinus rhythm.
• Advantages: Compared to other medications used for AF conversion, Vernakalant offers some potential benefits:
  • Faster conversion to normal rhythm.
  • Simpler administration through a single intravenous infusion.
  • Generally well-tolerated with fewer side effects.